193
Participants
Start Date
May 11, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
LOXO-783
Oral
Fulvestrant
Intramuscular
Imlunestrant
Oral
Abemaciclib
Oral
Anastrozole, Exemestane, or Letrozole
Oral
Paclitaxel
Intravenous
Institut Jules Bordet, Anderlecht
St Vincent's Hospital, Sydney
Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven
Peter Maccallum Cancer Institute Erb, East Melbourne
Cancer Research SA, Adelaide
Asan Medical Center, Seoul
Memorial Sloan Kettering Cancer Center, New York
Wilmot Cancer Institute, Rochester
Hospital General Universitario Gregorio Maranon, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Quironsalud Madrid, Pozuelo de Alarcón
Winship Cancer Center Emory University, Atlanta
Mayo Clinic, Jacksonville
Tennessee Oncology PLLC, Nashville
Institut de Cancérologie de l'Ouest, Saint-Herblain
Hospital Clinico Universitario de Valencia, Valencia
Hospital Arnau de Vilanova Valencia, Valencia
Washington University Medical School, St Louis
ICANS_Institut de Cancerologie Strasbourg Europe, Strasbourg
Centre Leon Berard, Lyon
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
Institut Curie, Paris
University of Texas MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics (START), San Antonio
Mayo Clinic of Scottsdale, Scottsdale
UCLA Medical Center, Los Angeles
Universitätsklinikum Erlangen, Erlangen
UCSF Medical Center at Mission Bay, San Francisco
Stanford University Hospital, Stanford
Gustave Roussy, Villejuif
Beijing Cancer hospital, Beijing
National Cancer Centre Singapore, Singapore
Fudan University Shanghai Cancer Center, Shanghai
The Third Hospital of Nanchang, Nanchang
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston
Mayo Clinic, Rochester
UT Southwestern Medical Center, Dallas
Princess Margaret Hospital (Hong Kong), Toronto
BC Cancer Vancouver, Vancouver
National Cancer Center Hospital, Chūōku
The Cancer Institute Hospital of JFCR, Kōtō City
Kyoto University Hospital, Kyoto
Aichi Cancer Center Hospital, Nagoya
Samsung Medical Center, Seoul
Hospital Universitario Quiron Dexeus, Barcelona
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Clinic de Barcelona, Barcelona
Royal Marsden NHS Trust, London
Royal Marsden Hospital (Sutton), Sutton
Eli Lilly and Company
INDUSTRY